Literature DB >> 16928221

Helicobacter pylori status and the extent of gastric atrophy do not affect ulcer healing after endoscopic submucosal dissection.

Naomi Kakushima1, Mitsuhiro Fujishiro, Naohisa Yahagi, Shinya Kodashima, Masanori Nakamura, Masao Omata.   

Abstract

BACKGROUND: Eradication therapy for Helicobacter pylori is effective in preventing peptic ulcer recurrence, but its efficacy in ulcer healing is still controversial. The effect of H. pylori on artificial ulcers after endoscopic resection is not known. The purpose of the present study was therefore to evaluate the influence of H. pylori infection on ulcer healing after endoscopic submucosal dissection (ESD).
METHODS: One hundred and 10 patients who underwent ESD for gastric tumors, and for whom the infection status of H. pylori was confirmed before treatment, were included. The healing stage was studied by endoscopy performed at 8 weeks after ESD. In addition, 73 patients whose serum pepsinogen (PG) was evaluated before ESD, were divided into three groups: PG positive (PGI<or=70 ng/mL and I/II<or=3 ng/mL), strongly positive (PGI<or=30 ng/mL and I/II<or=2 ng/mL) and negative, to study the influence of atrophic gastritis on ulcer healing.
RESULTS: Ulcer healing was observed in 85 patients (93%) who were H. pylori positive, and in 19 patients (100%) in whom H. pylori had been eradicated previously. Serum PG level had no influence on the healing process. Among 15 patients with ulceration or ulcer scar with the lesion, ulcer healing was observed in nine patients (60%), which was significantly low.
CONCLUSIONS: Infection status of H. pylori and the extent of gastric atrophy do not affect ulcer healing after ESD. Preoperative existence of fibrotic change in the submucosal layer may delay the healing process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16928221     DOI: 10.1111/j.1440-1746.2006.04321.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  30 in total

1.  Optimal duration of proton pump inhibitor for healing artificial ulcers after endoscopic submucosal dissection for early gastric cancer.

Authors:  Takuji Gotoda
Journal:  Dig Dis Sci       Date:  2011-12-25       Impact factor: 3.199

2.  Management of bleeding and artificial gastric ulcers associated with endoscopic submucosal dissection.

Authors:  Yosuke Muraki; Shotaro Enomoto; Mikitaka Iguchi; Mitsuhiro Fujishiro; Naohisa Yahagi; Masao Ichinose
Journal:  World J Gastrointest Endosc       Date:  2012-01-16

3.  Comparison of the efficacy of 4- and 8-week lansoprazole treatment for ESD-induced gastric ulcers: a randomized, prospective, controlled study.

Authors:  Ji Hoon Park; Eun Kyung Baek; Chang Hwan Choi; Kyung Hun Lee; Beom Jin Kim; Jeong Wook Kim; Jae Gyu Kim; Sae Kyung Chang
Journal:  Surg Endosc       Date:  2013-08-31       Impact factor: 4.584

4.  Optimal duration of proton pump inhibitor in the treatment of endoscopic submucosal dissection-induced ulcers: a retrospective analysis and prospective validation study.

Authors:  Suck-Ho Lee; Chang Kyun Lee; Il-Kwun Chung; Yun Suk Shim; Tae Hoon Lee; Sae Hwan Lee; Hong-Soo Kim; Sang-Heum Park; Sun-Joo Kim
Journal:  Dig Dis Sci       Date:  2011-10-15       Impact factor: 3.199

Review 5.  Endoscopic submucosal dissection for gastrointestinal neoplasms.

Authors:  Naomi Kakushima; Mitsuhiro Fujishiro
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

6.  Effects of steroid use for stenosis prevention after wide endoscopic submucosal dissection for gastric neoplasm.

Authors:  Yoshihiro Kishida; Naomi Kakushima; Kohei Takizawa; Masaki Tanaka; Noboru Kawata; Masao Yoshida; Sayo Ito; Kenichiro Imai; Hirotoshi Ishiwatari; Kinichi Hotta; Hiroyuki Matsubayashi; Hiroyuki Ono
Journal:  Surg Endosc       Date:  2017-07-21       Impact factor: 4.584

Review 7.  Endoscopic submucosal dissection for stomach neoplasms.

Authors:  Mitsuhiro Fujishiro
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

8.  Adverse events associated with endoscopic dilation for gastric stenosis after endoscopic submucosal dissection for early gastric cancer.

Authors:  Yoshihiro Kishida; Naomi Kakushima; Noboru Kawata; Masaki Tanaka; Kohei Takizawa; Kenichiro Imai; Kinichi Hotta; Hiroyuki Matsubayashi; Hiroyuki Ono
Journal:  Surg Endosc       Date:  2015-03-18       Impact factor: 4.584

9.  Risk factors of delayed ulcer healing after gastric endoscopic submucosal dissection.

Authors:  Joo Hyun Lim; Sang Gyun Kim; Jeongmin Choi; Jong Pil Im; Joo Sung Kim; Hyun Chae Jung
Journal:  Surg Endosc       Date:  2015-03-05       Impact factor: 4.584

10.  Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection--a randomized controlled study.

Authors:  Tomohiro Kato; Hiroshi Araki; Fumito Onogi; Takashi Ibuka; Akihiko Sugiyama; Eiichi Tomita; Masahito Nagaki; Hisataka Moriwaki
Journal:  J Gastroenterol       Date:  2009-12-03       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.